Azoitei, N., Hoffmann, C. M., Ellegast, J. M., Ball, C. R., Obermayer, K., Gößele, U., . . . Scholl, C. (2012). Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33. The Rockefeller University Press.
Citación estilo ChicagoAzoitei, Ninel, et al. Targeting of KRAS Mutant Tumors By HSP90 Inhibitors Involves Degradation of STK33. The Rockefeller University Press, 2012.
Cita MLAAzoitei, Ninel, et al. Targeting of KRAS Mutant Tumors By HSP90 Inhibitors Involves Degradation of STK33. The Rockefeller University Press, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.